Truist maintains Buy on Collegium Pharmaceutical; cuts price target to $49
Truist Securities maintained a Buy on Collegium Pharmaceutical and cut its price target to $49.00 per share from $58.00, per Benzinga/TradingView.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.